The global orthopedic surgery landscape is witnessing a significant shift towards minimally invasive procedures, particularly in the treatment of proximal femoral fractures. Trochanteric Fixation Nails (TFN) have become the gold standard for stabilizing intertrochanteric fractures, especially in the aging population where osteoporosis is prevalent.
Statistically, the incidence of hip fractures is projected to increase significantly by 2050 due to the global aging trend. This has fueled a massive demand for intramedullary fixation systems that offer superior biomechanical stability and allow for early weight-bearing. Professional surgeons now prioritize "Load-Sharing" over "Load-Bearing" implants to promote natural bone healing.
Market Growth: The global orthopedic trauma fixation market is expanding at a CAGR of 6.5%, with Asia-Pacific being the fastest-growing region due to infrastructure improvement and healthcare access.
Modern Trochanteric Fixation Nails are predominantly crafted from Titanium Alloy (Ti-6Al-4V ELI). This provides the perfect balance of biocompatibility, fatigue resistance, and a modulus of elasticity closer to human bone compared to stainless steel.
The evolution from standard Gamma nails to PFNA (Proximal Femoral Nail Antirotation) systems involves a helical blade or integrated screw systems that significantly improve stability in osteoporotic bone, preventing "cut-out" failures.
Using CAD/CAM and Finite Element Analysis (FEA), Chinese manufacturers optimize the nail's curvature and locking hole placement to minimize stress shielding and potential periprosthetic fractures.
Success Rate
Quality Certified
Exporting Countries
Technical Support
Procuring orthopedic implants from China has transitioned from a cost-saving measure to a strategic quality-driven decision. Leading China Suppliers now compete on the same technological plane as European and American counterparts while maintaining supply chain agility.
Global medical distributors look for three pillars: Reliability, Value, and Education. A top-tier Chinese supplier doesn't just sell a nail; they provide a surgical solution including the instrument kit, surgical technique manuals, and clinical evidence.
For procurement officers, the ability to source directly from a Foshan-based medical hub ensures reduced lead times and direct communication with R&D engineers.
Trochanteric Fixation Nails are designed for a variety of clinical scenarios, from high-energy trauma in young patients to fragility fractures in the elderly.
Ideal for 31-A1, A2, and A3 types (AO/OTA classification). The intramedullary approach reduces blood loss and surgical time compared to DHS plates.
Long intramedullary nails provide the necessary bypass for subtrochanteric extensions, ensuring stable fixation in high-stress zones.
Provides prophylactic stabilization for patients with metastatic bone disease, improving quality of life and mobility.
Foshan Wigivida Medical Co., Ltd. is a leading China-based manufacturer of high-quality medical consumables and devices, specializing in respiratory products, medical tubes, urology products, hypodermic and surgical consumables. With years of dedicated experience in the healthcare industry, Wigivida has built a reputation for providing reliable, safe, and innovative solutions to hospitals, clinics, and medical distributors worldwide.
The company offers a comprehensive product range, including oxygen masks, ventilator accessories, catheters, Foley catheters, hypodermic needles, syringes, surgical drapes, sterile gloves, sutures, cotton swabs, gauze rolls, IV sets, and disposable medical kits. Each product is manufactured with strict adherence to quality standards, ensuring biocompatibility, durability, and patient safety.
Wigivida Medical emphasizes innovation, research, and precision manufacturing, combining advanced production technology with a rigorous quality management system. The company also provides customized solutions to meet the specific needs of healthcare providers, supporting efficient hospital workflows and minimizing infection risks.
Guided by the principles of "quality first, service first, and customer satisfaction-driven," Foshan Wigivida Medical Co., Ltd. has earned an excellent reputation both domestically and internationally. With a professional R&D team, modern manufacturing facilities, and dedicated after-sales service, the company continues to advance the medical consumables industry, delivering safe, effective, and high-quality healthcare solutions that improve patient outcomes and support global healthcare innovation.
Wigivida Medical
